15.90Open15.90Pre Close0 Volume0 Open Interest97.00Strike Price0.00Turnover105.47%IV-2.61%PremiumMay 9, 2025Expiry Date17.96Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9887Delta0.0053Gamma4.40Leverage Ratio-0.0150Theta-0.0031Rho-4.35Eff Leverage0.0020Vega
Merck & Co Stock Discussion
For the revenue consensus estimate, analysts anticipate revenue around $15.48 billion, which would be a slight decrease of about 1.9% year-over-year.
Wall Street expects Merck to report EPS of approximately $2.16. This would r...
Landmark Trial: Merck's New PAH Drug Shows Stunning 76% Reduction in Life-Threatening Events
No comment yet